| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $74.4M | +4.0% | +37.1% |
| R&D Expense | $7.5M | -7.1% | +27.1% |
| SG&A Expense | $46.5M | +4.7% | +3.3% |
| Operating Income | $6.7M | +50.2% | +152.2% |
| Income Tax | $0 | — | +100.0% |
| Net Income | $621K | +132.2% | +103.9% |
| EPS (Basic) | $0.00 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $91.6M | +54.5% | +54.6% |
| Accounts Receivable | $53.8M | +1.3% | +30.7% |
| Inventory | $67.5M | +0.3% | +49.5% |
| Current Assets | $224.0M | +20.7% | +37.6% |
| Total Assets | $370.2M | +10.6% | +15.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $8.6M | — | — |
| Investing Cash Flow | -$363K | — | — |
| Financing Cash Flow | $11.7M | — | — |
| +100.0% |
| +100.0% |
| EPS (Diluted) | $0.00 | +100.0% | +100.0% |
| $116.2M |
| +22.1% |
| +27.7% |
| Long-term Debt | $219.5M | +0.4% | +1.5% |
| Total Liabilities | $371.1M | +4.8% | +6.2% |
| Stockholders' Equity | -$861K | +95.5% | +97.0% |